Sphingosine-1-phosphate enhancement of cortical actomyosin organization in cultured human schlemm's canal endothelial cell monolayers

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 12, 2010, Pages 6633-6638

  Sumida, Grant M ^a   Daniel Stamer, W ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; F ACTIN; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN LIGHT CHAIN; RAC PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SPHINGOSINE 1 PHOSPHATE;

ARTICLE; CELL CULTURE; CELL JUNCTION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REACTION TIME; SCHLEMM CANAL; UMBILICAL VEIN ENDOTHELIAL CELL;

ACTINS; ACTOMYOSIN; BETA CATENIN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, CORNEAL; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOBLOTTING; LYSOPHOSPHOLIPIDS; MICROSCOPY, FLUORESCENCE; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; RAC GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; SPHINGOSINE; TIME FACTORS; TRABECULAR MESHWORK; UMBILICAL VEINS;

EID: 79955561473     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5391     Document Type: Article

References (25)

1. Takuwa Y, Okamoto Y, Yoshioka K, Takuwa N. Sphingosine-1- phosphate signaling and biological activities in the cardiovascular system. Biochim Biophys Acta. 2008;1781:483-488.
2. Rosen H, Gonzalez-Cabrera PJ, Sanna MG, Brown S. Sphingosine1-phosphate receptor signaling. Annu Rev Biochem. 2009;78:743-768.
3. Chun J, Goetzl EJ, Hla T, et al. International Union of Pharmacology. XXXIV: lysophospholipid receptor nomenclature. Pharmacol Rev. 2002;54:265-269.
4. Murata N, Sato K, Kon J, et al. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J. 2000;352(pt 3): 809-815.
5. Liliom K, Guan Z, Tseng JL, Desiderio DM, Tigyi G, Watsky MA. Growth factor-like phospholipids generated after corneal injury. Am J Physiol. 1998;274:C1065-C1074.
6. Mettu PS, Deng PF, Misra UK, Gawdi G, Epstein DL, Rao PV. Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility. Invest Ophthalmol Vis Sci. 2004;45:2263-2271.
7. Stamer WD, Read AT, Sumida GM, Ethier CR. Sphingosine-1-phosphate effects on the inner wall of Schlemm's canal and outflow facility in perfused human eyes. Exp Eye Res. 2009;89:980-988.
8. Grant WM. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol. 1963;69:783-801.
9. Rosenquist R, Epstein D, Melamed S, Johnson M, Grant WM. Outflow resistance of enucleated human eyes at two different perfusion pressures and different extents of trabeculotomy. Curr Eye Res. 1989;8:1233-1240.
10. Maepea O, Bill A. Pressures in the juxtacanalicular tissue and Schlemm's canal in monkeys. Exp Eye Res. 1992;54:879-883.
11. Johnson M, Shapiro A, Ethier CR, Kamm RD. Modulation of outflow resistance by the pores of the inner wall endothelium. Invest Ophthalmol Vis Sci. 1992;33:1670-1675.
12. Lee MJ, Thangada S, Claffey KP, et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine- 1-phosphate. Cell. 1999;99:301-312.
13. Lee JF, Zeng Q, Ozaki H, et al. Dual roles of tight junctionassociated protein, zonula occludens-1, in sphingosine 1-phosphate- mediated endothelial chemotaxis and barrier integrity. J Biol Chem. 2006;281:29190-29200.
14. Mehta D, Konstantoulaki M, Ahmmed GU, Malik AB. Sphingosine 1-phosphate-induced mobilization of intracellular Ca2+ mediates rac activation and adherens junction assembly in endothelial cells. J Biol Chem. 2005;280:17320-17328.
15. Garcia JG, Liu F, Verin AD, et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest. 2001;108:689-701.
16. Dudek SM, Jacobson JR, Chiang ET, et al. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem. 2004;279: 24692-24700.
17. Wang L, Dudek SM. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res. 2009;77:39-45.
18. Donati C, Bruni P. Sphingosine 1-phosphate regulates cytoskeleton dynamics: implications in its biological response. Biochim Biophys Acta. 2006;1758:2037-2048.
19. Stamer WD, Roberts BC, Howell DN, Epstein DL. Isolation, culture, and characterization of endothelial cells from Schlemm's canal. Invest Ophthalmol Vis Sci. 1998;39:1804-1812.
20. Stamer WD, Seftor RE, Williams SK, Samaha HA, Snyder RW. Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr Eye Res. 1995;14:611-617.
21. Ren XD, Kiosses WB, Schwartz MA. Regulation of the small GTPbinding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 1999;18:578-585.
22. Kimura K, Ito M, Amano M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 1996; 273:245-248.
23. Wojciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ. Rho andRac but not Cdc42 regulate endothelial cell permeability. J Cell Sci. 2001;114:1343-1355.
24. Overby DR, Stamer WD, Johnson M. The changing paradigm of outflow resistance generation: towards synergistic models of the JCT and inner wall endothelium. Exp Eye Res. 2009;88:656-670.
25. Sanna MG, Wang SK, Gonzalez-Cabrera PJ, et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol. 2006;2:434-441.